ok so does that mean each company would eventually have to conduct their own trials with there own products?
So 2.5 billion in revenue comes from every company using DEP tech on their own products that Jackie can imagine?
so perhaps while possible, entirely up to the company to do so and to go through the trials all based on it also being profitable for them? No good paying SPL a royalty if it doesn’t improve your bottom line?
Webinar this Friday 8th April with Jackie Fairley, page-45
-
- There are more pages in this discussion • 24 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.5¢ |
Change
-0.003(3.06%) |
Mkt cap ! $39.17M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 10.0¢ | 9.5¢ | $12.55K | 130.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 586785 | 9.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 9.7¢ | 56840 | 1 |
View Market Depth
| Last trade - 16.10pm 23/07/2024 (20 minute delay) ? |
| SPL (ASX) Chart |